239
Updated and future aesthetic toxins
Saturday 03 February 2024
14:00 to 15:30
Amphi Havane - Level 3
FOCUS SESSION
Chair(s)
Dr. Benjamin ASCHER
Plastic Surgeon
France
Prof. Mark Steven NESTOR
Dermatologist
United States
Lectures of the session
14:12
PrabotulinumtoxinA 40U long-duration formulation, phase II study final results - Evolus
14:58
The pioneer and innovator: Asia's first FDA-approved Botulinum Toxin, Prabotulinumtoxin A - New indication introduction - Daewoong
15:08
New clinical evidence of LetibotulinumtoxinA: beyond Asia to the world - Hugel
15:30